Compass Therapeutics CMPX
NASDAQ CMPX
$0.83 -0.01 (-0.93%)
At close: Nov 11, 2026 · 4:00 PM EST

Compass Therapeutics (CMPX) Operating Margin (2024)

Updated

Compass Therapeutics (CMPX) recorded Operating Margin of -6661.76% in FY2024.

Analysis

Compass Therapeutics (CMPX) Operating Margin (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 Compass Therapeutics 151.27 Mn -597.53 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 -1,770.00%
API Access

Compass Therapeutics Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=CMPX&period=max&api_key=YOUR_API_KEY